Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease.
Friedman
J
J
D000368:Aged; D000369:Aged, 80 and over; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines; D018491:Dopamine Agonists / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D010300:Parkinson Disease / Q000188:drug therapy*; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011605:Psychoses, Substance-Induced / Q000188:drug therapy*
D014150:Antipsychotic Agents; D018491:Dopamine Agonists; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine